Kraig Biocraft Laboratories, Inc. KBLB
OTC PK
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -15.77% | 16.04% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -14.79% | 14.22% | |||
| Operating Income | 14.79% | -14.22% | |||
| Income Before Tax | 3.52% | -19.69% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 3.52% | -19.69% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 3.52% | -19.69% | |||
| EBIT | 14.79% | -14.22% | |||
| EBITDA | 15.01% | -14.57% | |||
| EPS Basic | 11.11% | -28.57% | |||
| Normalized Basic EPS | 16.67% | -20.00% | |||
| EPS Diluted | 11.11% | -28.57% | |||
| Normalized Diluted EPS | 16.67% | -20.00% | |||
| Average Basic Shares Outstanding | 1.79% | 0.96% | |||
| Average Diluted Shares Outstanding | 1.79% | 0.96% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||